Robert L. Rosiello, EVP, Chief Financial Officer at Valeant Pharmaceuticals International, Inc. (VRX), bought 7,875 shares at $253.99 ($2.0M) on 2015-07-30, disclosed to the SEC on 2015-08-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $253.99 | 7,171 | $1.8M | 91.0% |
| 2 | $257.25 | 704 | $181K | 9.0% |
| Total | $254.28 avg | 7,875 | $2.0M | 100% |